Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
AVROBIO, Inc. | $1.40 | $68.24 M | 2.2 | 13 | $0 | ||
Beam Therapeutics Inc. | $23.12 | $1.91 B | -14.51 | 346 | $377.71 M | ||
Caribou Biosciences, Inc. | $1.59 | $176.12 M | -1.41 | 158 | $34.48 M | ||
CohBar, Inc. | $0.51 | $2.33 M | -0.18 | 9 | $0 | ||
Editas Medicine, Inc. | $4.58 | $435.86 M | -2.56 | 265 | $78.12 M | ||
Fate Therapeutics, Inc. | $3.17 | $418.90 M | -1.92 | 181 | $63.53 M | ||
Hepion Pharmaceuticals, Inc. | $1.06 | $6.02 M | -0.12 | 22 | $0 | ||
Krystal Biotech, Inc. | $184.28 | $4.70 B | 75.42 | 229 | $50.70 M | ||
Intellia Therapeutics, Inc. | $22.73 | $2.19 B | -4.23 | 526 | $36.28 M | ||
Novo Nordisk A/S | $142.43 | $606.41 B | 49.27 | 66015 | $232.26 B | ||
Rain Therapeutics Inc. | $1.21 | $44.01 M | -0.58 | 63 | $0 | ||
Regeneron Pharmaceuticals, Inc. | $1,033.97 | $108.69 B | 29.65 | 13677 | $13.12 B | ||
Sarepta Therapeutics, Inc. | $151.71 | $11.66 B | 286.79 | 1314 | $1.24 B | ||
Verve Therapeutics, Inc. | $5.25 | $409.24 M | -1.82 | 255 | $11.76 M |